|
| 36831373 | Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma. | Cancers (Basel) | 2023 |
| 37638000 | Oncogenic Ras and οNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis. | Front Immunol | 2023 |
| 36831373 | Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma. | Cancers (Basel) | 2023 |
| 37463106 | SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. | Cell Rep | 2023 |
| 37055579 | Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). | Cell Death Differ | 2023 |
| 37638000 | Oncogenic Ras and οNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis. | Front Immunol | 2023 |
| 37055579 | Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). | Cell Death Differ | 2023 |
| 37463106 | SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. | Cell Rep | 2023 |
| 35176168 | Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. | Mol Cancer Res | 2022 |
| 35176168 | Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. | Mol Cancer Res | 2022 |
| 34167951 | The Proteomic Landscape of Growth Factor Signaling Networks Associated with <i>FAT1</i> Mutations in Head and Neck Cancers. | Cancer Res | 2021 |
| 34167951 | The Proteomic Landscape of Growth Factor Signaling Networks Associated with <i>FAT1</i> Mutations in Head and Neck Cancers. | Cancer Res | 2021 |
| 33737574 | Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. | Sci Rep | 2021 |
| 33838214 | Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis. | Int J Radiat Oncol Biol Phys | 2021 |
| 34931021 | Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes. | Commun Biol | 2021 |
| 33737574 | Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. | Sci Rep | 2021 |
| 33838214 | Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis. | Int J Radiat Oncol Biol Phys | 2021 |
| 34931021 | Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes. | Commun Biol | 2021 |
| 31520587 | A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease. | Transl Res | 2020 |
| 31645352 | Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells. | Clin Cancer Res | 2020 |
| 32002309 | ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer. | Oncoimmunology | 2020 |
| 33036368 | Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma? | Cancers (Basel) | 2020 |
| 32633234 | Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. | Elife | 2020 |
| 31520587 | A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease. | Transl Res | 2020 |
| 31645352 | Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells. | Clin Cancer Res | 2020 |
| 32002309 | ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer. | Oncoimmunology | 2020 |
| 33036368 | Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma? | Cancers (Basel) | 2020 |
| 32633234 | Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. | Elife | 2020 |
| 30420444 | Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. | Clin Cancer Res | 2019 |
| 31646086 | Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition. | Oncoimmunology | 2019 |
| 31624067 | Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. | Cancer Immunol Res | 2019 |
| 30488488 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. | Mol Carcinog | 2019 |
| 30420444 | Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. | Clin Cancer Res | 2019 |
| 31266830 | Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. | Clin Cancer Res | 2019 |
| 30944253 | Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. | JCI Insight | 2019 |
| 31345380 | Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. | Oral Oncol | 2019 |
| 31646086 | Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition. | Oncoimmunology | 2019 |
| 31266830 | Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. | Clin Cancer Res | 2019 |
| 31345380 | Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. | Oral Oncol | 2019 |
| 31624067 | Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. | Cancer Immunol Res | 2019 |
| 30944253 | Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. | JCI Insight | 2019 |
| 30488488 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. | Mol Carcinog | 2019 |
| 28727298 | Nine patients with chronic granulomatous disease having selective neck dissection for severe cervical lymphadenitis. | Clin Otolaryngol | 2018 |
| 28727298 | Nine patients with chronic granulomatous disease having selective neck dissection for severe cervical lymphadenitis. | Clin Otolaryngol | 2018 |
| 29884408 | The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck. | Oral Oncol | 2018 |
| 30393585 | Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. | Oncoimmunology | 2018 |
| 29921694 | Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. | Cancer Res | 2018 |
| 30201513 | Corrigendum to "The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck" [Oral Oncol. 81 (2018) 100-108]. | Oral Oncol | 2018 |
| 29959199 | Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133<sup>+</sup> Skin Cancer Stem Cells. | Mol Cancer Ther | 2018 |
| 30380422 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. | Cell Rep | 2018 |